Overexpression of an Immune Checkpoint (CD155) in Breast Cancer Associated with Prognostic Significance and Exhausted Tumor-Infiltrating Lymphocytes: A Cohort Study
Table 2
Association between CD155 expression and clinical pathological features.
Percentage of tumor cells with CD155 overexpression
Cell counts of CD4+ TILs, correlation coefficient†
126
0.226
0.011
Cell counts of CD4+/PD1+ TILs, correlation coefficient†
126
0.341
<0.001
Cell counts of CD8+ TILs, correlation coefficient†
126
0.213
0.017
Cell counts of CD8+/PD1+ TILs, correlation coefficient†
